Trials / Recruiting
RecruitingNCT05756179
Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Clinical Study Evaluating the Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis
Detailed description
Evaluation of the anti inflammatory and antioxidant effects of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis. Clinical and functional assessment of disease activity. Evaluation of hepatoprotective effect against methotrexate induced liver adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diosmin and Hesperidin Combination | Diosmin 450 mg and Hesperidin 50 mg Combination |
Timeline
- Start date
- 2023-07-18
- Primary completion
- 2025-09-01
- Completion
- 2026-09-01
- First posted
- 2023-03-06
- Last updated
- 2025-04-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05756179. Inclusion in this directory is not an endorsement.